Largest biotech companies in the United States by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Gilead Sciences leads the 20 biotech companies in the United States ranked by net assets, at DKK 154.5B, ahead of Biogen (DKK 124.2B) and Amgen (DKK 58.9B). Figures as of 20 Nov 2026, 07:46 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
20
First
Gilead SciencesDKK 154.5B
Median
DKK 10.9B
Combined market value
DKK 5T
Countries
1

Market values as of .

United States
All sectors
Biotech
DKK
Clear filters
Largest biotech companies in the United States by net assets
#CompanyNet assets ↓Market capPriceToday1 yearPrice, 30 daysCountry
1Gilead SciencesGILD · Health CareDKK 154.5BDKK 1.41TDKK 1,133.10 1.45% down 35% up United States
2BiogenBIIB · Health CareDKK 124.2BDKK 248.6BDKK 1,681.51 1.70% down 49% up United States
3AmgenAMGN · Health CareDKK 58.9BDKK 1.62TDKK 2,985.81 1.14% down 32% up United States
4ModernaMRNA · Health CareDKK 58.9BDKK 548.8BDKK 1,356.28 1.29% up 780% up United States
5Neurocrine BiosciencesNBIX · Health CareDKK 22.1BDKK 107.8BDKK 1,065.46 3.85% down 17% up United States
6VaxcytePCVX · Health CareDKK 18.3BDKK 62.9BDKK 397.09 0.27% down 23% up United States
7ExelixisEXEL · Health CareDKK 14.7BDKK 109.3BDKK 447.92 3.60% down 63% up United States
8Bio-TechneTECH · Health CareDKK 14.3BDKK 77.7BDKK 494.66 0.07% down 24% up United States
9RepligenRGEN · Health CareDKK 14.3BDKK 74.1BDKK 1,158.68 1.38% down 12% up United States
10Revolution MedicinesRVMD · Health CareDKK 11.1BDKK 234.6BDKK 1,084.79 0.24% down 129% up United States
11Kymera TherapeuticsKYMR · Health CareDKK 10.7BDKK 69.4BDKK 812.35 1.44% down 87% up United States
12Krystal BiotechKRYS · Health CareDKK 8.3BDKK 63.7BDKK 2,148.89 0.15% up 54% up United States
13ImmunovantIMVT · Health CareDKK 5.8BDKK 45.8BDKK 221.27 1.96% down 46% up United States
14CG OncologyCGON · Health CareDKK 5.1BDKK 49.8BDKK 557.26 2.38% up 97% up United States
15Twist BioscienceTWST · Health CareDKK 3.2BDKK 51.8BDKK 759.48 4.07% down 346% up United States
16Scholar Rock HoldingSRRK · Health CareDKK 1.7BDKK 41.8BDKK 342.73 4.94% up 26% up United States
17Adaptive BiotechnologiesADPT · Health CareDKK 1.5BDKK 30.9BDKK 190.86 1.44% down 74% up United States
18Kodiak SciencesKOD · Health CareDKK 1.1BDKK 43.6BDKK 666.13 0.09% up 399% up United States
19Halozyme TherapeuticsHALO · Health CareDKK 332.1MDKK 72.2BDKK 633.06 2.88% down 39% up United States
20ImmunityBioIBRX · Health Care-DKK 3.4BDKK 47.6BDKK 44.70 1.94% down 232% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8042 DKK).

Questions and answers

Which biotech companies in the United States rank first by net assets?

Gilead Sciences (DKK 154.5B), Biogen (DKK 124.2B) and Amgen (DKK 58.9B) are the top three of the 20 biotech companies in the United States ranked by net assets as of 20 Nov 2026, 07:46 UTC.

How many biotech companies in the United States are in this ranking?

20 are ranked by net assets.

What are these biotech companies in the United States worth together?

The 20 biotech companies in the United States ranked by net assets have a combined market value of DKK 5T as of 20 Nov 2026, 07:46 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.